Waters Sells $200M in Senior Notes | GenomeWeb

NEW YORK (GenomeWeb News) – Waters has sold $200 million in senior notes in a private placement, it said in a filing with the US Securities and Exchange Commission today.

The firm sold three series of notes in the placement: $100 million of 3.4 percent Series F Senior Notes, due June 30, 2021; $50 million of 3.92 percent Series G Senior Notes, due June 30, 2024; and $50 million of Series H Floating Rate Senior Notes bearing interest at 3 month LIBOR plus 1.25 percent, due June 30, 2024.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.